Published on: January 06, 2020 at 10:30PM
Condition: Type 2 Diabetes
Interventions: Drug: IMP oral tablet; Drug: Placebo oral tablet
Sponsors: University of Leicester; Royal Surrey County Hospital NHS Foundation Trust; AstraZeneca
Recruiting
https://ift.tt/2Qt8KjG
Monday, 6 January 2020
New diabetes clinical trial: The Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.